Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Oct 2026.
- Largest single sale: $607K (13,000 shares) of Enliven Therapeutics, Inc. on Oct 1, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | Director | Jan 9, 2026 | Oct 5, 2026 |
| Olema Pharmaceuticals, Inc. (OLMA) | Director | Oct 17, 2023 | Jun 23, 2026 |
| Exelixis, Inc. (EXEL) | Former EVP & Chief Commerical Officer | Oct 24, 2011 | Sep 19, 2013 |
Also a director at
Recent filings
The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 1, 2026, Enliven Therapeutics, Inc.: sold 13,000 shares for $607K, no plan disclosed; 13,000 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.